Sientra (NASDAQ:SIEN) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Sientra (NASDAQ:SIEN) in a research note issued to investors on Tuesday. The firm issued a hold rating on the medical instruments supplier’s stock.

Sientra Stock Performance

The company has a 50-day moving average of $0.46 and a two-hundred day moving average of $1.20. The stock has a market cap of $2.08 million, a PE ratio of -0.03 and a beta of 2.04. Sientra has a twelve month low of $0.16 and a twelve month high of $4.94.

Hedge Funds Weigh In On Sientra

Large investors have recently modified their holdings of the business. Mirabella Financial Services LLP acquired a new position in shares of Sientra in the 1st quarter valued at $26,000. Advisor Group Holdings Inc. lifted its stake in shares of Sientra by 230.9% in the 1st quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 8,325 shares during the last quarter. Evoke Wealth LLC lifted its stake in shares of Sientra by 148.5% in the 4th quarter. Evoke Wealth LLC now owns 44,300 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 26,473 shares during the last quarter. LPL Financial LLC acquired a new position in shares of Sientra in the 2nd quarter valued at $31,000. Finally, Wolverine Trading LLC acquired a new position in shares of Sientra in the 2nd quarter valued at $32,000. Institutional investors and hedge funds own 15.38% of the company’s stock.

Sientra Company Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.